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AhShCt 
The VLDL receptor, a newly identified lipoprotein receptor, has a domain structure homologous with e LDL receptor but has one additional 
cysteine rich repeat in the ligand binding domain. To study the regulation of the VLDL receptor in vivo, we administered 17 a-ethinyl estradiol to 
rabbits and examined its effects on VLDL receptor mRNA levels in the heart, one of the organs with highly expressed VLDL receptors, by RNA 
blotting. The ventricular level of VLDL receptor mRNA increased ramatically after estradiol administration. We could not detect VLDL receptor 
mRNA in the liver even after estradiol administration. We have confirmed the enhanced expression of liver LDL receptor mRNA by estradiol, 
however, only weak expression of the LDL receptor was detected in the ventricle of the rabbit heart. These results suggest hat estradiol exerts its 
effect on the VLDL receptor gene expression in the heart. 
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1. Intraduction 
Very low density lipoprotein (VLDL) receptor cDNA 
was cloned by hybridization with a rabbit low density 
lipoprotein (LDL) receptor cDNA probe from LDL re- 
ceptor subtracted rabbit heart cDNA library [l]. The 
deduced amino acid sequence revealed the existence of 
a new lipoprotein receptor with close similarities to the 
LDL receptor [2] both in domain structure and exon- 
intron boundary organization, suggesting a common an- 
cestral origin [3]. The striking difference was an addi- 
tional cysteine-rich repeat in the ligand binding domain 
in the VLDL receptor. This rabbit VLDL receptor 
cDNA was introduced into LDL receptor-deficient cells 
[l]. The transfected cells bound fluorescent VLDL and 
/3-VLDL but not LDL. Furthermore, in contrast to the 
LDL receptor, the VLDL receptor mRNA is expressed 
in the heart, muscle and adipose tissue, which are active 
in fatty acid metabolism. So far the regulation of VLDL 
receptor expression has not been studied. In order to 
elucidate the role of this receptor in lipid metabolism in 
vivo, we administered pharmacological doses of ethinyl 
estradiol into rabbits and analyzed the VLDL receptor 
expression in their hearts and livers in comparison with 
LDL receptor expression. 
*Corresponding author. Fax: (81) (75) 771 9452. 
Abbreviations: LDL, low density lipoprotein; VLDL, very low density 
lipoprotein; B-VLDL, B-migrating very low density lipoprotein; 
WHHL, Watanabe heritable hyperlipidemic; LPL, lipoprotein lipase. 
2. Materials and methods 
2.1. Materials 
17 a-Ethinyl estradiol (catalog noE4876) and propylene glycol were 
obtained from Sigma Chemical Co. (St Louis, USA). [&*P]dCTP 
(> 3000 Ci/m mol) was obtained from Amersham Corp. Other chemi- 
cals were all of reagent grade. 
2.2. Animals and estradiol administration 
Male Japanese white rabbits (2.0 kg) were exposed to 12 h of light 
(6.00 h to 18.00 h) and 12 h of darkness (18.00 h to 6.00 h) daily for 
1 week prior to use. 17 a-Ethinyl estradiol was dissolved in propylene 
glycol (10 mg/ml) and administered subcutaneously around 10.00 h 
each day in a final volume of 1 ml with 2.5 or 5.0 mg/kg body weight. 
2.3. Isolation of RNA 
Tissues were dissected from rabbits anesthetized with pentobarbital 
in the morning of the day, quickly frozen in liquid nitrogen, and stored 
at -70°C. Total RNA was isolated by the guanidine thiocyanate 
method of Chirgwin et al. [4]. The yield of RNA ranged within 240- 
2480 ,@g tissue, depending on the kind of tissue. Poly (A)-containing 
RNA was enriched by using oligo(dT) latex (Roche). The yield of poly 
(A)-rich RNA was around 3.5% of total RNA. 
2.4. RNA blot hybridization analysis 
The procedure of MacMaster and Carmichael [5] was used. Total 
RNA or poly (A)-rich RNA was denatured by incubation at 5O’C for 
60 min in 10 mM sodium phosphate buffer pH 7.0 containing 1 M 
glyoxal and 50% diiethylsulphoxide and was electrophoresed on a 
1.0% agarose gel in 10 mM sodium phosphate buffer pH 6.8. After 
electrophoresis, the RNA was transferred to nitrocellulose paper 
(GeneScreen Plus, DuPont, Wilmington, USA), deglyoxylated with 
50 mM NaOH and hybridized with a cDNA probe labeled with 
[a-3ZP]CTP by random primer (Gibco BRL, Gaithersburg, USA). The 
probes used were as follows: the HindIII-Hind111 fragment of 2.6K 
base pairs derived from the plasmid pVLDLR1 [I] carrying rabbit very 
low density liproprotein receptor cDNA, the ApaI-ApaI fragment of 
1.5K base pairs derived from the plasmid pLDLRl1 [6] carrying rabbit 
liver low density liproprotein receptor cDNA; the NotI-JZcoRV frag- 
ment of 1.5K base pairs carrying human/?-actin cDNA [7]. Prehybridi- 
zation was performed at 42°C for 4 h in 50 mM sodium phosphate 
buffer pH 6.8 containing 50% formamide, 0.75 M NaCl, 75 mM triso- 
dium citrate, 0.02% polyvinyl-pyrrolidon-K90, 0.02% Ficoll 400 
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(Pharmacia Fine Chemicals, Uppsala, Sweden), 0.02% bovine serum 
albumin Fraction V from Sigma Chemical Co., St. Louis, USA, 250 
&ml sonicated denatured salmon sperm DNA and 0.1% sodium do- 
decyl sulfate. The hybridization solution contained, in addition, 2 ng/ml 
32P-labeled cDNA with a specific activity of 1.5 x lo9 counts/min@g. 
The hybridization temperature was 42°C for both VLDL receptor 
cDNA and LDL receptor cDNA. After hybridization for approxi- 
mately 14 h, the filters were washed at the same temperature for 1 h, 
blotted, covered with plastic wrap and autoradiographed at-70°C with 
intensifying screens (Quanta III, DuPont). 
3. Results and discussion 
In the first series of experiments (Fig. l), pairs of 
rabbits were treated with ethinyl estradiol and total 
RNA preparations derived from the ventricle of the 
heart of both animals were pooled and subjected to blot 
hybridization analysis with a rabbit VLDL receptor 
cDNA probe. Total RNA from pairs given 5.0 mgkg 
ethinyl estradiol for 4 days (lane 2 in Fig. 1A) and 8 days 
(lane 3 in Fig. 1A) contained about 2.5 times and 5 times 
VLDL receptor mRNA than did control rabbits which 
were sacrificed at 0 day (lane 1 in Fig. 1A). The filters 









Fig. 2. Blot hybridization analysis with the VLDL receptor cDNA 
probe of total RNA from rabbit ventricles treated with 2.5 mg/kg or 
5.0 kg/mg estradiol. Total RNA (20 mg) from rabbit heart ventricles 
treated with ethinyl estradiol at 2.5 mg/kg(A) or 5.0 mg/kg(B) were 
analyzed by same the procedure as in Fig. 1. Lane 1, total RNA from 
control rabbit; lane 2, 2 days ethinyl estradiol administraion; lane 3, 4 
days ethinyl estradiol; lane 4,6 days ethinyl estradiol. Markers are the 
same as in Fig. 1. 
were rehybridized with a human /Sactin cDNA probe. A 
signal band corresponding to /I-actin mRNA was de- 
tected in all lanes and there was no significant difference 
in band density among the lanes. Total RNA from gas- 
trocunemius were also analyzed (Fig. 1B). The level of 
VLDL receptor mRNA was increased two times with 
estradiol administration for 4 days (lane 2 in Fig. 1B) and 
8 days (lane 3 in Fig. 1B). 
In the second series of experiments, rabbits were 
treated with ethinyl estradiol at 2.5 mgkg (Fig. 2A) and 
5.0 mgkg (Fig. 2B) for 2,4, or 6 days. The ventricle and 
liver derived from each rabbit administered with ethinyl 
estradiol were analyzed. The results show that admini- 
stration of ethinyl estradiol gradually increased the level 
of VLDL receptor mRNA in the rabbit ventricle: in Fig. 
2A, VLDL receptor mRNA levels for 2.5 mgkg over 
2 days (lane 2), 4 days (lane 3) and 6 days (lane 4) were 
scored by densitometry scanning as 321%, 561% and 
684% of the control value (lane 1 in Fig. 2A). Rabbits 
treated at 5.0 mgkg estradiol, the same dose as in the 
first experimental series, also showed a large increase in 
VLDL receptor mRNA content, although at this dose 
-Actin - -Actin 
Fig. 1. Blot hybridization analysis with the rabbit VLDL receptor 
cDNA probe of total RNA from rabbit ventricles and gastrocnemius 
treated with estradiol at 5.0 mg/kg. Total RNA (20 pg) from rabbit 
heart ventricles (A) and gastrocnemius musle (B) following electropho- 
resis on an agarose gel, transfer to a nitrocellulose membrane, and 
hybridization with rabbit VLDL receptor cDNA(A) and then rehy- 
bridized with human /I-a&n cDNA probe. Lane 1, total RNA from 
control rabbit; lane 2, total RNA after 4 days of ethinyl estradiol 
administration; lane 3, 8 days ethinyl estradiol. Markers are 28s ribo- 
somal RNA and 18s ribosomal RNA. there was no relationship between VLDL receptor 
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Fig. 3. Blot hybridization analysis with the rabbit LDL receptor cDNA 
probe of total and poly (A) rich RNA from rabbit ventricle and liver 
treated with estradiol. Poly(A) RNA (20 pg) (lanes 1) and total RNA 
(20 pg) (lanes 2, 3 and 4) from rabbit ventricle (A) and liver (B) of 
rabbits treated with ethinyl estradiol at 2.5 mg/kg were analyzed by 
RNA blotting with rabbit LDL receptor cDNA probe. Lanes 1 and 2, 
control rabbit; lane 3, 4 days of estrdiol administration of 2.5 mg/kg 
ethinyl estradiol; lane 4, 6 days ethinyl estradiol. 
mRNA content and time of estradiol exposure (Fig. 2B). 
Under the same condition, LDL receptor mRNA was 
not detected in the heart ventricle total RNA preparation 
(Fig. 3A), although by using 20 pug of poly(A)-rich RNA 
we could co&m the presence of low levels of LDL 
receptor mRNA in the heart. It is, therefore, clear that 
in heart ventricle ethinyl estradiol greatly enhances the 
expression of VLDL receptor mRNA but not of LDL 
receptor mRNA. 
VLDL receptor mRNA was not detected in the liver 
even after the administration of estradiol (data not 
shown) but LDL receptor mRNA is expressed in rabbit 
livers (Fig. 3B) and its level was increased by the estra- 
diol treatment. This enhanced expression of LDL recep- 
tor mRNA in the liver by estradiol is consistent with the 
previous results [8-l 11. 
The current study has been designed to assess effects 
of estrogen on the expression of the VLDL receptor 
gene. Sterol represses the expression of LDL receptor in 
cultured THP-1 cells, but it does not change the expres- 
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sion of the VLDL receptor gene (unpublished observa- 
tion). It is reported that pharmacological doses of ethinyl 
estradiol induce the LDL receptor mRNA and its pro- 
tein in the rabbit liver [l 11. Increased LDL receptors in 
the liver enhance the catabolism of LDL and results in 
lower levels of plasma LDL. The precise mechanism of 
estradiol enhancement on LDL receptor expression is 
unknown. The S-flanking region of the VLDL receptor 
gene contains several regulatory elements including the 
half sites for interaction with estrogen receptors [3]. 
Whether or not the estrogen receptor interacts directly 
with the above sequence remains to be elucidated by 
further analyses of the promoter region. 
In Watanabe heritable hyperlipidemic (WHHL) rabbit, 
which is an animal model for the hereditary deficiency 
of LDL receptor, chylomicron remnant catabolism is not 
impaired [12]. This finding led to the hypothesis that, in 
the liver, there is a chyromicron remnant receptor which 
recognizes triglyceride rich apoE containing lipoprotein 
particles. Recently, LDL receptor-related protein has 
emerged as a candidate receptor for apoE containing 
lipoprotein particles [13]. In contrast, the VLDL recep- 
tor was not expressed significantly in the rabbit liver but 
was abundantly expressed in the heart, muscle and adi- 
pose tissue. So far, lipoprotein catabolism in the heart 
has not been studied intensively. It is thought hat VLDL 
particles are hydrolyzed by lipoprotein lipase (LPL) in 
the capillary lumen, liberating free fatty acid which then 
diffuses into muscle or adipose tissue cells. From the 
stand point of energy supply, the direct entry of triglyc- 
eride rich lipoprotein particle into cells via the VLDL 
receptor appears highly efficient. The VLDL receptor in 
the heart might therefore be a gate for basal energy 
supply. Alternatively, this novel lipoprotein receptor 
might function in the heart when energy demand is in- 
creased. To further clarify its function(s), regulation of 
VLDL receptor expression needs to be studied in pa- 
thological conditions, such as cardiac hypertrophy. 
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